New Cell Therapy Technology Set to Enter Clinical Trials in 2024

7/17/2024

New Hope for AML Patients: DSP-5336 Receives FDA Fast Track Designation

7/15/2024

FDA Fast Tracks New Drug for Advanced Leukemia

7/15/2024

LLS Invests Millions to Improve Access to Blood Cancer Care

7/10/2024

Moleculin's Promising New AML Treatment Awaits FDA Feedback

7/10/2024

New Cancer Drug Olverembatinib Approved for Use in Macau

7/8/2024

Promising Results from Phase I Trial for New Anticoagulant Drug

7/8/2024

Breakthrough in Anticoagulant Treatment: Promising Phase I Results for New RNAi Drug

7/8/2024

New Hope for Follicular Lymphoma: AbbVie’s Epcoritamab Gains Positive Review in Europe

6/28/2024

New Hope for Chronic Lymphocytic Leukemia Patients: Advocating for Next-Gen Treatment Inclusion

6/25/2024

New Guidelines Aim to Enhance Hemophilia Treatment Protocols

6/21/2024

Breakthrough Treatment CM313 Shows Promising Results for Immune Thrombocytopenia

6/20/2024

New Hope for Relapsed Multiple Myeloma and AL Amyloidosis Patients with Lisaftoclax

6/18/2024

Promising Results for Olverembatinib: A New Hope in Treating Resistant Leukemia

6/18/2024

Breakthrough Therapy for High-Risk Multiple Myeloma Shows Promising Results

6/16/2024

New Leaps in Acute Leukemia Treatments: DSP-5336 Shows Promise

6/15/2024

Groundbreaking Trial Enhances Outcomes for High-Risk Leukemia Patients

6/14/2024

Revumenib Shows Promise in Combating Acute Leukemias: Fresh Data from EHA 2024

6/14/2024

New FDA-Approved Device Brings Hope in Emergency Hemorrhage Control

6/13/2024

Novel Phone Therapy Boosts Well-Being in Blood Cancer Patients Post-Transplant

6/11/2024

Octapharma's Innovations for Bleeding Disorder Management to Shine at ISTH 2024

6/10/2024

Breakthrough Gene Therapy for Hemophilia A: Long-Term Success of ROCTAVIAN

6/7/2024

Blood Cancer Treatment: Phase I Trial of Menin Inhibitor Begins

6/7/2024

Groundbreaking Advances in Multiple Myeloma Treatment with DARZALEX® Therapy

6/3/2024

New Treatment Breakthrough Offers Hope for Relapsed Multiple Myeloma Patients

6/2/2024

AYVAKIT Shows Promising Results in Treating Rare Blood Disorder

5/31/2024

FDA Greenlights First Swappable Biosimilar for Rare Blood and Kidney Diseases

5/29/2024

FDA Paves the Way for New Biosimilar Treatment for Rare Blood Disorders

5/28/2024

Metformin: A Promising Ally in Reducing Blood Cancer Risk

5/27/2024

New Breakthrough in Stem Cell Therapy for Graft vs. Host Disease

5/23/2024

New Hope for Elderly Patients with Aggressive Blood Cancer

5/21/2024

AI-Powered Eye Scans Revolutionize Anemia Detection

5/16/2024

New Research Unveils Predictive Factors for Severe Sickle Cell Retinopathy

5/15/2024